These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31990387)

  • 1. Complement activation in sickle cell disease: Dependence on cell density, hemolysis and modulation by hydroxyurea therapy.
    Roumenina LT; Chadebech P; Bodivit G; Vieira-Martins P; Grunenwald A; Boudhabhay I; Poillerat V; Pakdaman S; Kiger L; Jouard A; Audureau E; Pirenne F; Galactéros F; Frémeaux-Bacchi V; Bartolucci P
    Am J Hematol; 2020 May; 95(5):456-464. PubMed ID: 31990387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravascular hemolysis activates complement via cell-free heme and heme-loaded microvesicles.
    Merle NS; Grunenwald A; Rajaratnam H; Gnemmi V; Frimat M; Figueres ML; Knockaert S; Bouzekri S; Charue D; Noe R; Robe-Rybkine T; Le-Hoang M; Brinkman N; Gentinetta T; Edler M; Petrillo S; Tolosano E; Miescher S; Le Jeune S; Houillier P; Chauvet S; Rabant M; Dimitrov JD; Fremeaux-Bacchi V; Blanc-Brude OP; Roumenina LT
    JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dense red blood cell and oxygen desaturation in sickle-cell disease.
    Di Liberto G; Kiger L; Marden MC; Boyer L; Poitrine FC; Conti M; Rakotoson MG; Habibi A; Khorgami S; Vingert B; Maitre B; Galacteros F; Pirenne F; Bartolucci P
    Am J Hematol; 2016 Oct; 91(10):1008-13. PubMed ID: 27380930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological parameters predictive of percent dense red blood cell decrease under hydroxyurea.
    Rakotoson MG; Di Liberto G; Audureau E; Habibi A; Fauroux C; Khorgami S; Hulin A; Loric S; Noizat-Pirenne F; Galacteros F; Bartolucci P
    Orphanet J Rare Dis; 2015 May; 10():57. PubMed ID: 25956133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble Fas/FasL ratio as a marker of vasculopathy in children and adolescents with sickle cell disease.
    Adly AA; Ismail EA; Andrawes NG; Mahmoud MM; Eladawy R
    Cytokine; 2016 Mar; 79():52-8. PubMed ID: 26765484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement activation during intravascular hemolysis: Implication for sickle cell disease and hemolytic transfusion reactions.
    Merle NS; Boudhabhay I; Leon J; Fremeaux-Bacchi V; Roumenina LT
    Transfus Clin Biol; 2019 May; 26(2):116-124. PubMed ID: 30879901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective regulation of complement by the sickle erythrocyte: evidence for a defect in control of membrane attack complex formation.
    Test ST; Woolworth VS
    Blood; 1994 Feb; 83(3):842-52. PubMed ID: 7507737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased levels of soluble ICAM-1 in the plasma of sickle cell patients are reversed by hydroxyurea.
    Conran N; Fattori A; Saad ST; Costa FF
    Am J Hematol; 2004 Aug; 76(4):343-7. PubMed ID: 15282666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyurea-induced expression of glutathione peroxidase 1 in red blood cells of individuals with sickle cell anemia.
    Cho CS; Kato GJ; Yang SH; Bae SW; Lee JS; Gladwin MT; Rhee SG
    Antioxid Redox Signal; 2010 Jul; 13(1):1-11. PubMed ID: 19951064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression pattern of CD55 and CD59 on red blood cells in sickle cell disease.
    Al-Faris L; Al-Rukhayes M; Al-Humood S
    Hematology; 2017 Mar; 22(2):105-113. PubMed ID: 27667587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red blood cells microparticles are associated with hemolysis markers and may contribute to clinical events among sickle cell disease patients.
    Olatunya OS; Lanaro C; Longhini AL; Penteado CFF; Fertrin KY; Adekile A; Saad STO; Costa FF
    Ann Hematol; 2019 Nov; 98(11):2507-2521. PubMed ID: 31493004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications.
    Tantawy AA; Adly AA; Ismail EA; Darwish YW; Ali Zedan M
    Blood Cells Mol Dis; 2014 Dec; 53(4):189-93. PubMed ID: 25065856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin generation in children with sickle cell disease: relationship with age, hemolysis, transcranial Doppler velocity, and hydroxyurea treatment.
    Noubouossie DC; Lê PQ; Rozen L; Ziereisen F; Willems D; Demulder A; Ferster A
    Eur J Haematol; 2013 Jul; 91(1):46-54. PubMed ID: 23530655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum apelin as a novel non-invasive marker for subclinical cardiopulmonary complications in children and adolescents with sickle cell disease.
    Elbarbary NS; Ismail EA; Roushdy A; Fahmy E
    Blood Cells Mol Dis; 2016 Mar; 57():1-7. PubMed ID: 26852648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrocyte density in sickle cell syndromes is associated with specific clinical manifestations and hemolysis.
    Bartolucci P; Brugnara C; Teixeira-Pinto A; Pissard S; Moradkhani K; Jouault H; Galacteros F
    Blood; 2012 Oct; 120(15):3136-41. PubMed ID: 22919030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous infusion of haptoglobin for the prevention of adverse clinical outcome in Sickle Cell Disease.
    Quimby KR; Hambleton IR; Landis RC
    Med Hypotheses; 2015 Oct; 85(4):424-32. PubMed ID: 26141635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Featured Article: Depletion of HDL
    Soupene E; Larkin SK; Kuypers FA
    Exp Biol Med (Maywood); 2017 Jun; 242(12):1244-1253. PubMed ID: 28436274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA sensitizes tumor cells to complement attack in vitro.
    Geis N; Zell S; Rutz R; Li W; Giese T; Mamidi S; Schultz S; Kirschfink M
    Curr Cancer Drug Targets; 2010 Dec; 10(8):922-31. PubMed ID: 20879979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: Relation to cardiovascular complications.
    Tantawy AA; Adly AA; Ismail EA; Habeeb NM; Farouk A
    Platelets; 2013; 24(8):605-14. PubMed ID: 23249216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels of TNF-alpha in sickle cell patients receiving hydroxyurea.
    Tavakkoli F; Nahavandi M; Wyche MQ; Perlin E
    Hematology; 2004 Feb; 9(1):61-4. PubMed ID: 14965870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.